Carson Wealth (CWM LLC)’s Tarsus Pharmaceuticals TARS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.9K	Buy	497 +94	+23%	+$6.57K	﹤0.01%	4059
2025 Q4	$33K	Buy	403 +13	+3%	+$971	﹤0.01%	3898
2025 Q3	$23K	Buy	390 +147	+60%	+$7.24K	﹤0.01%	4047
2025 Q2	$10K	Buy	243 +125	+106%	+$5.63K	﹤0.01%	4314
2025 Q1	$6K	Buy	118 +62	+111%	+$3.06K	﹤0.01%	4408
2024 Q4	$3K	Buy	56 +29	+107%	+$1.32K	﹤0.01%	4456
2024 Q3	$1K	Sell	27 -10	-27%	-$281	﹤0.01%	4718
2024 Q2	$1K	Buy	37 +35	+1,750%	+$1.18K	﹤0.01%	4491
2024 Q1	$0	Buy	+2	New	+$59	﹤0.01%	4731

Other funds holding TARS

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Carson Wealth (CWM LLC)'s TARS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Tarsus Pharmaceuticals (TARS) stake by 23% in Q1 2026, buying an estimated $6.57K and bringing the position to 497 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

Carson Wealth (CWM LLC) first reported a position in TARS in Q1 2024 and has held it in 9 quarters since. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

Carson Wealth (CWM LLC) held 497 shares of Tarsus Pharmaceuticals worth $34.9K as of Q1 2026.
Carson Wealth (CWM LLC) bought 94 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $6.57K.
Tarsus Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4059 holding.
Carson Wealth (CWM LLC) first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.